Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy

被引:23
作者
Albert, SM
Flater, SR
Clouse, R
Todak, G
Stern, Y
Marder, K
机构
[1] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA
[2] Columbia Univ, Dept Neurol, New York, NY 10032 USA
[3] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA
[4] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
medication management; HIV; cognitive status; dementia;
D O I
10.1023/A:1025404105378
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
People with HIV-related cognitive impairment may change the way they manage medication regimens, relying on a fixed medication schedule each day to avoid missed doses. Using a medication recall diary, we identified people who took medication on exactly the same schedule over 3 days and those with more variable medication schedules. Patients with low scores on executive and psychomotor tests were more likely to report fixed medication schedules; memory performance, by contrast, was not associated with reported medication regimen. Patients with low scores on executive and psychomotor tests were also less accurate in pouring medicines in the Medication Management Test. More than three fourths of these HIV+ patients assumed that medicines with higher milligram dosages were stronger than medicines with smaller milligram dosages, even across different classes of medicines. In a non-HIV sample, 28% endorsed the belief, suggesting it is a widespread way of thinking about medication strength. A performance test of medication management sheds light on the ways patients take medicines and how beliefs about medicines affect medication regimens.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 26 条
  • [1] NEUROPSYCHOLOGIC IMPAIRMENT IN EARLY HIV-INFECTION - A RISK FACTOR FOR WORK DISABILITY
    ALBERT, SM
    MARDER, K
    DOONEIEF, G
    BELL, K
    SANO, M
    TODAK, G
    STERN, Y
    [J]. ARCHIVES OF NEUROLOGY, 1995, 52 (05) : 525 - 530
  • [2] [Anonymous], 1999, AIDS and Behavior, DOI DOI 10.1023/A:1025483806464
  • [3] BENTON AL, 1951, VISUAL RETENTION TES
  • [4] Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments
    Chesney, MA
    Ickovics, JR
    Chambers, DB
    Gifford, AL
    Neidig, J
    Zwickl, B
    Wu, AW
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03): : 255 - 266
  • [5] NORMATIVE DATA FOR A BRIEF NEUROPSYCHOLOGIC TEST BATTERY IN A COHORT OF INJECTING DRUG-USERS
    CONCHA, M
    SELNES, OA
    MCARTHUR, JC
    NANCESPROSON, T
    UPDIKE, ML
    ROYAL, W
    SOLOMON, L
    VLAHOV, D
    [J]. INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1995, 30 (07): : 823 - 841
  • [6] Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors
    De Ronchi, D
    Faranca, I
    Berardi, D
    Scudellari, P
    Borderi, N
    Manfredi, R
    Fratiglioni, L
    [J]. ARCHIVES OF NEUROLOGY, 2002, 59 (05) : 812 - 818
  • [7] AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy
    Deutsch, R
    Ellis, RJ
    McCutchan, JA
    Marcotte, TD
    Letendre, S
    Grant, I
    [J]. AIDS, 2001, 15 (14) : 1898 - 1899
  • [8] Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
    Dore, GJ
    Correll, PK
    Li, YM
    Kaldor, JM
    Cooper, DA
    Brew, BJ
    [J]. AIDS, 1999, 13 (10) : 1249 - 1253
  • [9] Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function
    Ferrando, S
    van Gorp, W
    McElhiney, M
    Goggin, K
    Sewell, M
    Rabkin, J
    [J]. AIDS, 1998, 12 (08) : F65 - F70
  • [10] THE EFFECT OF PARKINSONS-DISEASE ON THE ABILITY TO MAINTAIN A MENTAL SET
    FLOWERS, KA
    ROBERTSON, C
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (06) : 517 - 529